Lv4
620 积分 2024-04-26 加入
Optimizing inpatient care for lung cancer patients with immune checkpoint inhibitor-related pneumonitis using a clinical care pathway algorithm
6小时前
待确认
Glycine 236 in the Lower Hinge Region of Human IgG1 Differentiates FcγR from Complement Effector Function
1天前
待确认
Evolving Landscape of Systemic Therapy for Hepatocellular Carcinoma in 2025
2天前
已完结
A phase II, randomized, open-label study to evaluate low-dose pembrolizumab plus chemotherapy versus chemotherapy as neoadjuvant therapy for localized triple-negative breast cancer (TNBC) (PLANeT trial—Pembrolizumab Low dose in Addition to NACT in TNBC)
10天前
已完结
Comprehensive Next-Generation Sequencing Reveals Novel Predictive Biomarkers of Recurrence and Thoracic Toxicity Risks After Chemoradiation Therapy in Limited Stage Small Cell Lung Cancer
14天前
已完结
Adebrelimab or placebo plus carboplatin and etoposide as first-line treatment for extensive-stage small-cell lung cancer (CAPSTONE-1): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
15天前
已完结
Multicentre phase II trial of cabozantinib in patients with hepatocellular carcinoma after immune checkpoint inhibitor treatment
21天前
已完结
Biosimilars and immunogenicity: a matter of concern?
27天前
已完结
Drift, Evolution, and Divergence in Biologics and Biosimilars Manufacturing
28天前
已完结
Bench to bedside: elucidation of the OPG–RANK–RANKL pathway and the development of denosumab
29天前
已完结
皖公网安备34019202002308
